1-5 of 5
Ole Baadsgaard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Zanolimumab (HuMax-CD4™), a Fully Human Monoclonal Antibody: Efficacy and Safety in Patients with Relapsed or Treatment-Refractory Non-Cutaneous CD4 + T-Cell Lymphoma.

Francesco d’Amore, MD, John Radford, MD, Mats Jerkeman, MD, Thomas Relander, MD, Herve Tilly, MD, Anders Osterborg, MD, Franck Morschhauser, MD, Martin Gramatzki, MD, Martin Dreyling, MD, Bo Bang, MD, Ole Baadsgaard, MD, Hans Hagberg, MD
Journal: Blood
Blood (2007) 110 (11): 3409.
https://doi.org/10.1182/blood.V110.11.3409.3409
Published: 2007
Journal Articles

Chemotherapy-Refractory Diffuse Large B-Cell Lymphomas (DLBCL) Are Effectively Killed by Ofatumumab-Induced Complement-Mediated Cytoxicity.

Saskia A.G.M. Cillessen, MSc, Wendy J.M. Mackus, PhD, Kitty C.M. Castricum, Wim Vos, Pim C. Kortman, Jan G.J. van de Winkel, PhD, Paul W.H.I. Parren, PhD, Chris J.L.M. Meijer, PhD, MD, Joost J. Oudejans, PhD, MD, (Intr. by Ole Baadsgaard)
Journal: Blood
Blood (2007) 110 (11): 2346.
https://doi.org/10.1182/blood.V110.11.2346.2346
Published: 2007
Journal Articles

Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma

Clinical Trials & Observations
Youn H. Kim, Madeleine Duvic, Erik Obitz, Robert Gniadecki, Lars Iversen, Anders Österborg, Sean Whittaker, Timothy M. Illidge, Thomas Schwarz, Roland Kaufmann, Kevin Cooper, Kim M. Knudsen, Steen Lisby, Ole Baadsgaard, Susan J. Knox
Journal: Blood
Blood (2007) 109 (11): 4655–4662.
https://doi.org/10.1182/blood-2006-12-062877
Published: 2007
Journal Articles

Zanolimumab, a Fully Human Monoclonal Antibody: Preliminary Results of an Ongoing Clinical Trial in CD4 + Peripheral T-Cell Lymphomas (PTCL).

Francesco d’Amore, MD, Thomas Relander, M.D., Mats Jerkeman, M.D., Hans Hagberg, M.D., Anders Osterborg, M.D., Peter Johnson, M.D., John A. Radford, M.D., Barry W. Hancock, M.D., Martin Gramatzki, M.D., Norbert Schmitz, M.D., Herve Tilly, M.D, Franck Morschhauser, M.D., STeen Lisby, M.D, Ole Baadsgaard, M.D
Journal: Blood
Blood (2006) 108 (11): 2723.
https://doi.org/10.1182/blood.V108.11.2723.2723
Published: 2006
Journal Articles

Zanolimumab, a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in Patients with CD4 + Mycosis Fungoides (MF) Type CTCL (Stage IB-IVB) Who Are Refractory or Intolerant to Targretin and One Other Standard Therapy.

Madeleine Duvic, MD, Youn Kim, M.D., Neil J. Korman, M.D., Erin Boh, M.D., Adam Lerner, M.D., Michael P. Heffernan, M.D., Kenneth B. Hymes, M.D., Theresa Pacheco, M.D., Craig A. Elmets, M.D., Steen Lisby, M.D., Ole Baadsgaard, M.D.
Journal: Blood
Blood (2006) 108 (11): 2731.
https://doi.org/10.1182/blood.V108.11.2731.2731
Published: 2006